CYCLOMICS

cyclomics-logo

Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses, particularly in the context of cancer recurrence thanks to its proprietary circulating tumor DNA (ctDNA) detection technology. Accurate measurement of cancer recurrence and monitoring of treatment responses are important clinical needs in cancer diagnostics. The limitations of existing (imaging-based) methods poses a significant impediment to effective (re-)treatment and overal... l survival. The mission of Cyclomics is to address this challenge through an innovative solution for early cancer detection called CyclomicsSeq. This solution consists of a new diagnostic kit that can disrupt the cancer diagnostics market and clinical practice by enabling fast and reliable results, and delivering superior performance to standard radiological and/or physical examination alone. CyclomicsSeq's first application will be for head and neck cancers (HNC), where monitoring of treatment response and recurrence disease is essential for improving survival.

#SimilarOrganizations #People #Financial #Website #More

CYCLOMICS

Industry:
Health Care

Founded:
2018-01-01

Address:
Utrecht, Utrecht, The Netherlands

Country:
The Netherlands

Website Url:
http://www.cyclomics.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
71.43 K EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome


Similar Organizations

aulos-bioscience-logo

Aulos Bioscience

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

inveox-logo

inveox

Automating histopathology, making cancer diagnoses faster, safer and more reliable.

Current Employees Featured

wigard-kloosterman_image

Wigard Kloosterman
Wigard Kloosterman Co-Founder and CSO @ Cyclomics
Co-Founder and CSO

jeroen-de-ridder_image

Jeroen de Ridder
Jeroen de Ridder Co-Founder and CEO @ Cyclomics
Co-Founder and CEO
2020-10-01

Founder


jeroen-de-ridder_image

Jeroen de Ridder

wigard-kloosterman_image

Wigard Kloosterman

Investors List

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - Cyclomics

Official Site Inspections

http://www.cyclomics.com

  • Host name: w98.rzone.de
  • IP address: 81.169.145.152
  • Location: Berlin Germany
  • Latitude: 52.5174
  • Longitude: 13.3985
  • Timezone: Europe/Berlin
  • Postal: 12529

Loading ...

More informations about "Cyclomics"

Cyclomics - Crunchbase Company Profile & Funding

The mission of Cyclomics is to address this challenge through an innovative solution for early cancer detection called CyclomicsSeq. This solution consists of a new diagnostic kit that can …See details»

RenovaroCube to Acquire 100% Ownership of Cyclomics, …

Apr 24, 2024 LOS ANGELES and AMSTERDAM, April 24, 2024 (GLOBE NEWSWIRE) - Renovaro Inc. (Nasdaq: RENB), a trailblazer in AI-driven early cancer diagnostics and …See details»

Cyclomics - VentureRadar

"Cyclomics is a Dutch startup company founded in 2018 by scientists of the UMC Utrecht. Its ambition is to transform cancer care by enabling faster and more reliable diagnoses, …See details»

Cyclomics Company Profile 2024: Valuation, Funding

Cyclomics General Information Description. Developer of cancer diagnostics and treatment monitoring technology designed to address medical and clinical needs. The company utilizes circulating tumor DNA (deoxyribonucleic acid) detection …See details»

Cyclomics - Company Profile - Tracxn

Dec 5, 2024 Cyclomics - Developer of liquid biopsybased diagnostic test for cancer detection. Raised funding over 1 round from 1 investor. Founded by Alessio Marcozzi, Jeroen De Ridder …See details»

Cyclomics - Products, Competitors, Financials, Employees, …

Cyclomics primarily serves the healthcare sector by providing diagnostic solutions that integrate into clinical workflows for enhanced decision-making in cancer care. It was founded in 2018 …See details»

Cyclomics - Contacts, Employees, Board Members, Advisors

Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. …See details»

Cyclomics - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Nov 1, 2024 Organization. Cyclomics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 20. Monthly …See details»

Cyclomics | Lifesciences @ Work

Cyclomics is a Dutch startup company founded in 2018 by scientists of the UMC Utrecht. Its ambition is to transform cancer care by enabling faster and more reliable diagnoses, particularly in the context of cancer recurrence thanks to …See details»

Cyclomics Company Profile - Office Locations, Competitors ... - Craft

Cyclomics has 5 employees at their 1 location. See insights on Cyclomics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Early detection of tumor DNA in liquid biopsies as a biomarker of ...

Aug 16, 2022 Cyclomics BV is a Dutch start-up company with the ambition to disrupt the cancer diagnostics market with its proprietary circulating tumor (ct) DNA detection technology. …See details»

Team - Cyclomics

Meet the expert team behind Cyclomics, a pioneering biotech company in cancer diagnostics and genomics. Our dedicated team of scientists, researchers, and industry leaders drive innovation …See details»

Cyclomics - Biotech Careers

Cyclomics is a Dutch startup company founded in 2018 by scientists of the UMC Utrecht. Its ambition is to transform cancer care by enabling faster and more reliable diagnoses, …See details»

Cyclomics starts new research collaboration with Oxford Nanopore ...

Mar 16, 2023 Cyclomics is an UMC Utrecht spinoff company, co-founded by Oncode Investigator Jeroen de Ridder.Cyclomics obtained initial funding via the Oncode Bridge …See details»

Renovarocube To Acquire 100% Ownership Of Cyclomics

Apr 24, 2024 LOS ANGELES and AMSTERDAM, April 24, 2024 (GLOBE NEWSWIRE) — Renovaro Inc. (Nasdaq: RENB), a trailblazer in AI-driven early cancer diagnostics and …See details»

Technology - Cyclomics

At Cyclomics, we are pioneering advancements in molecular diagnostics with our flagship technology, CyclomicsSeq. This cutting-edge liquid biopsy and consensus sequencing …See details»

Renovaro Cube acquires Cyclomics - 2024-04-24 - Crunchbase

Apr 24, 2024 Cyclomics Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses. Acquiring Organization: Renovaro Cube …See details»

Cyclomics | DNA Sequencing

Discover Cyclomics, pioneers in precision cancer diagnostics using breakthrough consensus-sequencing paired with the Nanopore platform. Our innovative solutions enable ultra-sensitive …See details»

News - Cyclomics

Jul 14, 2024 Cyclomics has completed a financing round with private investors to accelerate the development of innovative cancer genetic testing technologies. The new funding will allow …See details»

Services - Cyclomics

Explore Cyclomics' exclusive sequencing services, including CyclomicsSeq for ultra-sensitive mutation detection, MeCy for methylation analysis without bisulfite treatment, and PlasmidSeq …See details»

linkstock.net © 2022. All rights reserved